华润双鹤等在呼和浩特成立生物医药产业基金投资企业

Group 1 - The core point of the article is the establishment of a new investment partnership by China Resources Double Crane Pharmaceutical Industry Fund with a capital contribution of 500 million yuan [1] - The business scope of the newly formed partnership includes private equity investment, investment management, and asset management activities [1] - The partnership is jointly funded by China Resources Double Crane, China Resources Pharmaceutical Investment Co., Ltd., and China Resources Pharmaceutical Equity Investment Fund Management (Shantou) Co., Ltd. [1]